| 2401 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
67 |
| 2402 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2403 |
Apheresis |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
65 |
| 2404 |
Apheresis |
Autologous |
Anaplastic Lymphoma Kinase Positive Anaplastic Large-Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
37 |
| 2405 |
Apheresis |
Allogeneic |
Bare Lymphocyte Syndrome Type Ii |
Hematology |
2023 |
Standard Therapy |
Poland |
3 months |
| 2406 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2407 |
Apheresis |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
49 |
| 2408 |
Apheresis |
Autologous |
B-Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
66 |
| 2409 |
Apheresis |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
53 |
| 2410 |
Apheresis |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
27 |
| 2411 |
Apheresis |
Allogeneic |
B-Cell Precursor Acute Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2412 |
Apheresis |
Allogeneic |
Beta Thalassemia Major |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2413 |
Apheresis |
Allogeneic |
Blastic Plasmacytoid Dendritic Cell Neoplasm |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2414 |
Apheresis |
Allogeneic |
Cell Neoplasm |
Hematology |
2023 |
Standard Therapy |
Germany |
47 |
| 2415 |
Apheresis |
Allogeneic |
Chronic Lymphocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2416 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
43 |
| 2417 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
36 |
| 2418 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2419 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
59 |
| 2420 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
37 |
| 2421 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
41 |
| 2422 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2423 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
61 |
| 2424 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
54 |
| 2425 |
Apheresis |
Allogeneic |
Chronic Myelogenous Leukemia |
Hematology |
2023 |
Standard Therapy |
Germany |
28 |
| 2426 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2427 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
65 |
| 2428 |
Apheresis |
Allogeneic |
Chronic Myelomonocytic Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
64 |
| 2429 |
Apheresis |
Autologous |
Composite Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
71 |
| 2430 |
Apheresis |
Allogeneic |
Congenital Pulmonary Lymphangiectasia |
Hematology |
2023 |
Standard Therapy |
Poland |
50 |
| 2431 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
59 |
| 2432 |
Apheresis |
Allogeneic |
Diffuse Large B-Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
50 |
| 2433 |
Apheresis |
Autologous |
Diffuse Large B-Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
70 |
| 2434 |
Apheresis |
Allogeneic |
Ewing Sarcoma |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2435 |
Apheresis |
Autologous |
Follicular Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
62 |
| 2436 |
Apheresis |
Allogeneic |
Follicular Lymphoma |
Hematology |
2023 |
Standard Therapy |
Poland |
53 |
| 2437 |
Apheresis |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2023 |
Standard Therapy |
Poland |
4 months |
| 2438 |
Apheresis |
Autologous |
Hodgkin – Relapse |
Hematology |
2023 |
Standard Therapy |
Germany |
43 |
| 2439 |
Apheresis |
Allogeneic |
Huntington's Disease (Hd) |
Hematology |
2023 |
Standard Therapy |
Germany |
36 |
| 2440 |
Apheresis |
Allogeneic |
Hypoplastic Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
27 |
| 2441 |
Apheresis |
Allogeneic |
Immunodeficiency |
Hematology |
2023 |
Standard Therapy |
Poland |
4 |
| 2442 |
Apheresis |
Allogeneic |
Inherited Immune System Disorder |
Hematology |
2023 |
Standard Therapy |
Poland |
16 |
| 2443 |
Apheresis |
Allogeneic |
Langerhans Cell Sarcoma |
Hematology |
2023 |
Standard Therapy |
Poland |
66 |
| 2444 |
Apheresis |
Autologous |
Light-Chain Amyloidosis |
Hematology |
2023 |
Standard Therapy |
Germany |
62 |
| 2445 |
Apheresis |
Allogeneic |
Macrofocal Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Poland |
94 |
| 2446 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
54 |
| 2447 |
Apheresis |
Autologous |
Mantle Cell Lymphoma |
Hematology |
2023 |
Standard Therapy |
Germany |
64 |
| 2448 |
Apheresis |
Allogeneic |
Mast Cell Sarcoma, Systemic Mastocytosis Nr |
Hematology |
2023 |
Standard Therapy |
Poland |
51 |
| 2449 |
Apheresis |
Allogeneic |
Mixed Phenotype Acute Leukemia |
Hematology |
2023 |
Standard Therapy |
Poland |
64 |
| 2450 |
Apheresis |
Autologous |
Morbus Hodgkin |
Hematology |
2023 |
Standard Therapy |
Germany |
43 |
| 2451 |
Apheresis |
Autologous |
Morbus Hodgkin |
Hematology |
2023 |
Standard Therapy |
Germany |
57 |
| 2452 |
Apheresis |
Allogeneic |
Mucopolysaccharidosis /Myelodysplastic Syndrome Overlap |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2453 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
47 |
| 2454 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
53 |
| 2455 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
65 |
| 2456 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
60 |
| 2457 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2458 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2459 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
72 |
| 2460 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
61 |
| 2461 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
68 |
| 2462 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
54 |
| 2463 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
67 |
| 2464 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
69 |
| 2465 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
61 |
| 2466 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2467 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2468 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
61 |
| 2469 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
64 |
| 2470 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
69 |
| 2471 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
58 |
| 2472 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
56 |
| 2473 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
66 |
| 2474 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2475 |
Apheresis |
Allogeneic |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Poland |
56 |
| 2476 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
53 |
| 2477 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
66 |
| 2478 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
59 |
| 2479 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
59 |
| 2480 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
64 |
| 2481 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
63 |
| 2482 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
68 |
| 2483 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
60 |
| 2484 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
42 |
| 2485 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
62 |
| 2486 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
50 |
| 2487 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
59 |
| 2488 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
56 |
| 2489 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
64 |
| 2490 |
Apheresis |
Autologous |
Multiple Myeloma |
Hematology |
2023 |
Standard Therapy |
Germany |
59 |
| 2491 |
Apheresis |
Allogeneic |
Mycosis Fungoides |
Hematology |
2023 |
Standard Therapy |
Poland |
62 |
| 2492 |
Apheresis |
Allogeneic |
Myelodysplastic Disorders |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2493 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
71 |
| 2494 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
64 |
| 2495 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
67 |
| 2496 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
56 |
| 2497 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
41 |
| 2498 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
70 |
| 2499 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
57 |
| 2500 |
Apheresis |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2023 |
Standard Therapy |
Poland |
70 |